Interferon-β Therapy in a Patient with Incontinentia Pigmenti and Autoantibodies against Type I IFNs Infected with SARS-CoV-2

JOURNAL OF CLINICAL IMMUNOLOGY

SPRINGER/PLENUM PUBLISHERS

1. Howard Hughes Medical Institute
2. Rockefeller University
3. St. Giles Foundation
4. National Institutes of Health (NIH) [R01AI088364]
5. National Center for Advancing Translational Sciences (NCATS), NIH Clinical and Translational Science Award (CTSA) program [UL1 TR001866]
6. Emergent Ventures
7. Yale Center for Mendelian Genomics
8. GSP Coordinating Center - National Human Genome Research Institute (NHGRI) [UM1HG006504, U24HG008956]
9. French National Research Agency (ANR) under the Investments for the Future program [ANR10-IAHU-01]
10. Integrative Biology of Emerging Infectious Diseases Laboratory of Excellence [ANR-10-LABX-62-IBEID]
11. French Foundation for Medical Research (FRM) [EQU201903007798]
12. FRM
13. ANR GENCOVID project [ANRS-COV05]
14. Square Foundation
15. Grandir - Fonds de solidarite pour l'enfance
16. SCOR Corporate Foundation for Science
17. Institut National de la Sante et de la Recherche Medicale (INSERM)
18. University of Paris
19. MD-PhD program of the Imagine Institute (Fondation Bettencourt-Schueller)
20. Fondation Bettencourt-Schueller
21. Mercatus Center at George Mason University